M. S. Cohen, Y. Q. Chen, M. Mccauley, T. Gamble, M. C. Hosseinipour et al., Prevention of HIV-1 infection with early antiretroviral therapy, N Engl J Med, vol.365, issue.6, pp.493-505, 2011.

R. M. Grant, J. R. Lama, P. L. Anderson, V. Mcmahan, A. Y. Liu et al., Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, N Engl J Med, vol.363, issue.27, pp.2587-99, 2010.

S. Mccormack, D. T. Dunn, M. Desai, D. I. Dolling, M. Gafos et al., Preexposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial, Lancet, vol.387, pp.53-60, 2016.

J. Molina, C. Capitant, B. Spire, G. Pialoux, L. Cotte et al., On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection, N Engl J Med, vol.373, issue.23, pp.2237-2283, 2015.
URL : https://hal.archives-ouvertes.fr/halshs-01429281

, Policy Brief: WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP), 2015.

M. Jansen, N. Tromp, and R. Baltussen, PrEP: why we are waiting, Lancet HIV, vol.3, issue.1, pp.11-13, 2016.

S. A. Golub, K. E. Gamarel, and A. Surace, Demographic differences in PrEPrelated stereotypes: implications for implementation, AIDS Behav, vol.21, issue.5, pp.1229-1264, 2017.

S. A. Golub, PrEP messaging: taking "Risk" out of the pitch. Oral Presentation at HIVR4P: HIV Research for Prevention, 2018.

S. Madrid,

S. A. Golub and J. E. Myers, Next-wave HIV pre-exposure prophylaxis implementation for gay and bisexual men, AIDS Patient Care STDS, vol.33, issue.6, pp.253-261, 2019.

J. E. Myers and K. A. Sepkowitz, A pill for HIV prevention: D ej a Vu all over again?, Clin Infect Dis, vol.56, issue.11, pp.1604-1616, 2013.

E. S. Watkins, On the pill: a social history of oral contraceptives, vol.208, 1950.

T. A. Farley, D. A. Cohen, R. H. Kahn, S. Lolis, G. Johnson et al., The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention, Sex Transm Dis, vol.30, issue.11, p.844, 2003.

R. R. Willcox, A world look at the venereal diseases: recrudescence of the venereal diseases, Med Clin North Am, vol.56, issue.5, pp.1057-71, 1972.

M. Hogben and N. Liddon, Disinhibition and risk compensation: scope, definitions, and perspective, Sex Transm Dis, vol.35, issue.12, p.1009, 2008.

L. Ti and T. Kerr, The impact of harm reduction on HIV and illicit drug use, Harm Reduct J, vol.11, p.7, 2014.

E. Wood, J. S. Montaner, and T. Kerr, Illicit drug addiction, infectious disease spread, and the need for an evidence-based response, Lancet Infect Dis, vol.8, issue.3, pp.142-145, 2008.

E. A. Voth, Harm reduction drug policy, Lancet Infect Dis, vol.8, issue.9, p.528, 2008.

E. G. Raymond and M. A. Weaver, Effect of an emergency contraceptive pill intervention on pregnancy risk behavior, Contraception, vol.77, issue.5, pp.333-339, 2008.

C. L. Macphail, J. N. Sayles, W. Cunningham, and P. A. Newman, Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans, Qual Health Res, vol.22, issue.5, pp.668-78, 2012.

B. T. Hansen, No evidence that HPV vaccination leads to sexual risk compensation. Hum Vaccines Immunother, vol.12, pp.1451-1454, 2016.

M. L. Kasting, S. Wilson, B. E. Dixon, S. M. Downs, A. Kulkarni et al., Healthcare providers' beliefs and attitudes regarding risk compensation following HPV vaccination, Papillomavirus Res, vol.2, pp.116-137, 2016.

J. Blumenthal and R. Haubrich, Risk compensation in PrEP: an old debate emerges yet again, Virtual Mentor, vol.16, issue.11, pp.909-924, 2014.

M. Holt and D. A. Murphy, Individual versus community-level risk compensation following preexposure prophylaxis of HIV, Am J Public Health, vol.107, issue.10, pp.1568-71, 2017.

M. M. Cassell, D. T. Halperin, J. D. Shelton, and D. Stanton, Risk compensation: the Achilles' heel of innovations in HIV prevention?, BMJ, vol.332, issue.7541, pp.605-612, 2006.

L. A. Eaton and S. C. Kalichman, Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies, Curr HIV/AIDS Rep, vol.4, issue.4, pp.165-72, 2007.

J. D. Auerbach and T. A. Hoppe, Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV, J Int AIDS Soc, vol.18, p.4, 2015.

K. Koester, R. K. Amico, H. Gilmore, A. Liu, V. Mcmahan et al., Risk, safety and sex among male PrEP users: time for a new understanding, Cult Health Sex, vol.19, issue.12, pp.1301-1314, 2017.

J. Milam, S. Jain, M. P. Dube, E. S. Daar, X. M. Sun et al., Sexual risk compensation in a pre-exposure prophylaxis demonstration study among individuals at risk for HIV, J Acquir Immune Defic Syndr, vol.80, issue.1, pp.9-13, 2019.

R. Castro, D. Fugon, L. Bourgeois-fisson, E. Gall, J. Barbier et al., Swiss Statement": Who knows about it? How do they know? What are its effects on people living with HIV/AIDS?, AIDS Care, vol.24, issue.8, pp.1013-1022, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00879819

M. Unemo, C. S. Bradshaw, J. S. Hocking, H. De-vries, S. C. Francis et al., Sexually transmitted infections: challenges ahead, Lancet Infect Dis, vol.17, issue.8, pp.235-79, 2017.

J. N. Wasserheit, Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases, Sex Transm Dis, vol.19, issue.2, pp.61-77, 1992.

D. T. Fleming and J. N. Wasserheit, From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection, Sex Transm Infect, vol.75, issue.1, pp.3-17, 1999.

R. F. Leeman, B. A. Toll, and J. R. Volpicelli, The Drinking-Induced Disinhibition Scale (DIDS): a measure of three types of disinhibiting effects, UNAIDS. Miles to go. Closing gaps, breaking barriers, righting injustices [Internet], vol.32, pp.1200-1219, 2007.

M. T. Fillmore and J. Weafer, Alcohol impairment of behavior in men and women, Addict Abingdon Engl, vol.99, issue.10, pp.1237-1283, 2004.

G. Wilde, Target risk: dealing with the danger of death, disease and damage in everyday decisions, 1994.

S. Peltzman, The effects of automobile safety regulation, J Polit Econ, vol.83, issue.4, pp.677-725, 1975.

G. C. Blomquist, The Regulation of Motor Vehicle and Traffic Safety, vol.145, 1988.

J. Adams, Smeed's Law, seat belts and the emperor's new clothes, pp.193-248, 1985.

J. Adams and J. Adams, Risk and freedom: the record of road safety regulation, 1985.

J. Adams, Risk homeostasis and the purpose of safety regulation. Ergonomics, vol.31, pp.407-435, 1988.

J. Hedlund, Risky business: safety regulations, risk compensation, and individual behavior, Inj Prev, vol.6, issue.2, pp.82-91, 2000.

M. Fishbein and I. Ajzen, Belief, attitude, intention, and behavior: an introduction to theory and research, vol.600, 1975.

R. Castro and D. , Journal of the International AIDS Society, vol.2019, issue.S6

B. H. Sheppard, J. Hartwick, and P. R. Warshaw, The theory of reasoned action: a meta-analysis of past research with recommendations for modifications and future research, J Consum Res, vol.15, issue.3, pp.325-368, 1988.

I. Ajzen, The theory of planned behavior, Organ Behav Hum Decis Process, vol.50, issue.2, pp.179-211, 1991.

I. Ajzen and M. Fishbein, Understanding attitudes and predicting social behavior, 1980.

J. O. Prochaska and W. F. Velicer, The transtheoretical model of health behavior change, Am J Health Promot AJHP, vol.12, issue.1, pp.38-48, 1997.

J. D. Fisher and W. A. Fisher, Changing AIDS-risk behavior, Psychol Bull, vol.111, issue.3, pp.455-74, 1992.

W. A. Fisher and J. D. Fisher, A general social psychological model for changing AIDS risk behavior, pp.127-153, 1993.

W. A. Fisher and J. D. Fisher, Understanding and promoting sexual and reproductive health behavior: theory and method, Annu Rev Sex Res, vol.9, issue.1, pp.39-76, 1998.

R. Fuller, A conceptualization of driving behaviour as threat avoidance. Ergonomics, vol.27, pp.1139-55, 1984.

R. Naeaetaenen and H. Summala, Road-User Behaviour And Traffic Accidents

N. Publ and . Co, , 1976.

H. Molen, A hierarchical risk model for traffic participants, Ergonomics, vol.31, issue.4, pp.537-55, 1988.

G. Wilde, The theory of risk homeostasis: implications for safety and health, Risk Anal, vol.2, issue.4, pp.209-234, 1982.

J. Adams, The risk compensation theory and bicycle helmets, Inj Prev, vol.7, issue.2, pp.89-91, 2001.

G. Wilde, Does risk homoeostasis theory have implications for road safety, BMJ, vol.324, issue.7346, pp.1149-52, 2002.

T. W. Hoyes, N. A. Stanton, and R. G. Taylor, Risk homeostasis theory: a study of intrinsic compensation, Saf Sci, vol.22, issue.1, pp.77-86, 1996.

P. Taylor-gooby and J. O. Zinn, Current directions in risk research: new developments in psychology and sociology, Risk Anal, vol.26, issue.2, pp.397-411, 2006.

B. O'neill and A. Williams, Risk homeostasis hypothesis: a rebuttal, Inj Prev, vol.4, issue.2, pp.92-95, 1998.

D. C. Thompson, Risk compensation theory should be subject to systematic reviews of the scientific evidence, Inj Prev, vol.7, issue.2, pp.86-94, 2001.

R. M. Trimpop, Risk homeostasis theory: problems of the past and promises for the future, Saf Sci, vol.22, issue.1, pp.119-149, 1996.

K. Schleinitz, T. Petzoldt, and T. Gehlert, Risk compensation? The relationship between helmet use and cycling speed under naturalistic conditions, J Safety Res, vol.67, pp.165-71, 2018.

M. Esmaeilikia, I. Radun, R. Grzebieta, and J. Olivier, Bicycle helmets and risky behaviour: a systematic review, Transp Res Part F Traffic Psychol Behav, vol.60, pp.299-310, 2019.

K. Underhill, Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: balancing methodological rigor and research ethics, Soc Sci Med, vol.94, pp.115-138, 2013.

N. Crepaz, T. A. Hart, and G. Marks, Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review, JAMA, vol.292, issue.2, pp.224-260, 2004.

J. M. Baeten, D. Donnell, P. Ndase, N. R. Mugo, J. D. Campbell et al.,

, Antiretroviral prophylaxis for HIV prevention in heterosexual men and women, N Engl J Med, vol.367, issue.5, pp.399-410, 2012.

M. C. Thigpen, P. M. Kebaabetswe, L. A. Paxton, D. K. Smith, C. E. Rose et al., Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana, N Engl J Med, vol.367, issue.5, pp.423-457, 2012.

L. Van-damme, A. Corneli, K. Ahmed, K. Agot, J. Lombaard et al., Preexposure prophylaxis for HIV infection among African women, N Engl J Med, vol.367, issue.5, pp.411-433, 2012.

G. Guest, D. Shattuck, L. Johnson, B. Akumatey, E. Clarke et al., Changes in sexual risk behavior among participants in a PrEP HIV prevention trial, Sex Transm Dis, vol.35, issue.12, pp.1002-1010, 2008.

J. Richens, J. Imrie, and A. Copas, Condoms and seat belts: the parallels and the lessons, Lancet, vol.355, pp.400-403, 2000.

K. F. Ortblad, G. Harling, N. Chimbindi, F. Tanser, and J. A. Salomon, Does incident circumcision lead to risk compensation? Evidence from a population cohort in, J Acquir Immune Defic Syndr, vol.80, issue.3, pp.269-275, 2019.

N. Westercamp, K. Agot, W. Jaoko, and R. C. Bailey, Risk compensation following male circumcision: results from a two-year prospective cohort study of recently circumcised and uncircumcised men in Nyanza Province, AIDS Behav, vol.18, issue.9, pp.1764-75, 2014.

J. A. Kelly, L. L. Otto-salaj, K. J. Sikkema, S. D. Pinkerton, F. Bloom et al., Sexual risk behaviour increases and is associted with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to, Health Psychol, vol.17, issue.4, pp.2951-2954, 1998.

R. H. Remien, G. Wagner, A. Carballo-di-eguez, and C. Dolezal, Who may be engaging in high-risk sex due to medical treatment advances?, AIDS Lond Engl, vol.12, issue.12, pp.1560-1561, 1998.

S. Y. Chen, S. Gibson, M. H. Katz, J. D. Klausner, J. W. Dilley et al., Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men, Am J Public Health, vol.92, issue.9, pp.1387-1395, 1999.

M. H. Katz, S. K. Schwarcz, T. A. Kellogg, J. D. Klausner, J. W. Dilley et al., Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco, Am J Public Health, vol.92, issue.3, pp.388-94, 2002.

I. G. Stolte, N. H. Dukers, J. B. De-wit, J. S. Fennema, and R. A. Coutinho, Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART, Sex Transm Infect, vol.77, issue.3, pp.184-190, 2001.

P. Vernazza, B. Hirschel, E. Bernasconi, and M. Flepp, Les personnes s eropositives ne souffrant d'aucune autre MST et suivant un traitement antir etroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull M edecins Suisses, vol.89, pp.165-174, 2008.

J. S. Doyle, L. Degenhardt, A. E. Pedrana, E. S. Mcbryde, R. J. Guy et al., Effects of HIV antiretroviral therapy on sexual and injecting risk-taking behavior: a systematic review and meta-analysis, Clin Infect Dis, vol.59, issue.10, pp.1483-94, 2014.

M. Gafos, R. Horne, W. Nutland, G. Bell, C. Rae et al., The context of sexual risk behaviour among men who have sex with men seeking PrEP, and the impact of PrEP on sexual behaviour, AIDS Behav, vol.23, issue.7, pp.1708-1720, 2019.

I. Rivierez, G. Quatremere, B. Spire, J. Ghosn, R. Castro et al., Lessons learned from the experiences of informal PrEP users in France: results from the ANRS-PrEPage study, AIDS Care, vol.30, issue.2, pp.48-53, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02101188

V. A. Fonner, S. L. Dalglish, C. E. Kennedy, R. Baggaley, K. R. O'reilly et al., Effectiveness and safety of oral HIV preexposure prophylaxis for all populations, AIDS Lond Engl, vol.30, issue.12, pp.1973-83, 2016.

M. W. Traeger, S. E. Schroeder, E. J. Wright, M. E. Hellard, V. J. Cornelisse et al., Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis, Clin Infect Dis, vol.67, issue.5, pp.676-86, 2018.

S. M. Jenness, K. M. Weiss, S. M. Goodreau, T. Gift, H. Chesson et al., Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study, Clin Infect Dis, vol.65, issue.5, pp.712-720, 2017.

A. Kofman and E. Y. Adashi, Pre-exposure prophylaxis for the primary prevention of HIV in at-risk women: empowerment and equity revisited, AIDS Rev, vol.16, issue.3, pp.134-177, 2014.

K. H. Mayer and D. S. Krakower, Editorial commentary: uncoupling epidemiological synergy: new opportunities for HIV prevention for men who have sex with men, Clin Infect Dis, vol.61, issue.2, pp.288-90, 2015.

S. Morel, Promoting sexual health through community education and activism: How community involvement could improve sexual health access & STI test regularity. Presentation at: STI 2018: Understanding and Addressing the HIV and STI Syndemics, 2018.

T. Amsterdam and . Netherlands,

K. M. Wall, C. M. Khosropour, and P. S. Sullivan, Offering of HIV screening to men who have sex with men by their healthcare providers and associated factors, J Int Assoc Physicians AIDS Care (Chic), vol.9, issue.5, pp.284-292, 2010.

K. Underhill, K. M. Morrow, C. Colleran, R. Holcomb, S. K. Calabrese et al., A qualitative study of medical mistrust, perceived discrimination, and risk behavior disclosure to clinicians by U.S. male sex workers and other men who have sex with men: implications for biomedical HIV prevention, J Urban Health, vol.92, issue.4, pp.667-86, 2015.

K. H. Mayer, Do ask, do tell: clinicians and the U.S. National AIDS strategy, AIDS Lond Engl, vol.28, issue.8, pp.1233-1238, 2014.

. Anrs.-l'-etude-anrs-pr-evenir-d-emarre, , 2017.

T. Whitfield, S. A. John, H. J. Rendina, C. Grov, and J. T. Parsons, Why I quit Pre-Exposure Prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP

R. Castro and D. , discontinuation and potential re-initiation among gay and bisexual men, Journal of the International AIDS Society, vol.22, issue.S6, pp.3566-75, 2018.

K. C. Coy, R. J. Hazen, H. S. Kirkham, A. Delpino, and A. J. Siegler, Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, J Int AIDS Soc, vol.22, issue.2, p.25252, 2015.

D. Krakower, K. M. Maloney, V. E. Powell, K. Levine, C. Grasso et al., Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care, J Int AIDS Soc, vol.22, issue.2, p.25250, 2019.

J. Molina, I. Charreau, C. Chidiac, G. Pialoux, E. Cua et al., Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial, Lancet Infect Dis, vol.18, issue.3, pp.308-325, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02096653

R. K. Bolan, M. R. Beymer, R. E. Weiss, R. P. Flynn, A. A. Leibowitz et al., Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study, Sex Transm Dis, vol.42, issue.2, pp.98-103, 2015.

M. Siguier and J. Molina, Doxycycline prophylaxis for bacterial sexually transmitted infections: promises and perils, ACS Infect Dis, vol.4, issue.5, pp.660-663, 2018.

M. W. Traeger, V. J. Cornelisse, J. Asselin, B. Price, N. J. Roth et al., Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection, JAMA, vol.321, issue.14, pp.1380-90, 2019.

N. Low, N. Broutet, Y. Adu-sarkodie, P. Barton, M. Hossain et al., Global control of sexually transmitted infections, Lancet, vol.368, issue.9551, pp.2001-2017, 2006.

E. Fee, Sin vs. science: venereal disease in Baltimore in the twentieth century, J Hist Med Allied Sci, vol.43, issue.2, pp.141-64, 1988.

R. Castro and D. , Journal of the International AIDS Society, vol.2019, issue.S6